A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL
Not yet recruiting · NCT05931757 · Registry updated 2023-07-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL | Philadelphia-Positive ALL | Not yet recruiting | Phase 2 | 2023-07-05 | NCT05931757 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Soochow University | 164 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| First Affiliated Hospital of Soochow University | Suzhou | China | 5 |